Current Issue
Biopharma Asia
January/February 2023 | Volume 12 Issue 1
De-Bottlenecking Scale-up Challenges for Large Scale Viral Vector Manufacturing for Gene T...
Prateek Gupta, Senior Vice President, Technical Development and MSAT, Manish Sharma, Gener...
Variability, Limits, and Other Considerations for the Next Generation of Pyrogen and Endot...
Karen Zink McCullough, Owner, Principal Consultant, MMI Associates, LLC
Current Evolution in the Space of CM: What is Happening and What is Coming Up: Continuous ...
Lawrence De Belder, Continuous Manufacturing Practice Lead, Pharmatech Associates, Inc.
Stepping into the Future of Biopharmaceutical Production with PAT
Martin Gadsby, Vice President, Optimal Industrial Technologies
Cell Culture Platform Technologies in Speed-Up CMC Process
H. Fai Poon, President, Jun Yuan, CTO, Wayne Wenyan Xu, Vice President of Research and Dev...
Move Your Gene Therapy from Strategy to Reality
Matt Niloff, Director, Integrated Solutions, Pall Corporation, David Sokolowski, Global Pr...